I think there is a real opportunity for DVA and FMS to improve profit margins under a bundled payment rate. They could do subQ EPO, and titrate to the low end of the HG range. This alone would mean huge savings, maybe also less frequent lab tests. As long as they can continue to do the best for patients. Any thoughts on this, especially form naybody who works in a facility would be appreciated.